Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses.

Singer-Berk MH, Knickelbein KE, Lounsberry ZT, Crausaz M, Vig S, Joshi N, Britton M, Settles ML, Reilly CM, Bentley E, Nunnery C, Dwyer A, Lassaline ME, Bellone RR.

Int J Genomics. 2019 Sep 15;2019:3610965. doi: 10.1155/2019/3610965. eCollection 2019.

2.

A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for ocular squamous cell carcinoma in Belgian horses.

Knickelbein KE, Lassaline ME, Singer-Berk M, Reilly CM, Clode AB, Famula TR, Michau TM, Bellone RR.

Equine Vet J. 2019 Mar 23. doi: 10.1111/evj.13116. [Epub ahead of print]

PMID:
30903710
3.

Genetic risk for squamous cell carcinoma of the nictitating membrane parallels that of the limbus in Haflinger horses.

Singer-Berk M, Knickelbein KE, Vig S, Liu J, Bentley E, Nunnery C, Reilly C, Dwyer A, Drögemüller C, Unger L, Gerber V, Lassaline M, Bellone RR.

Anim Genet. 2018 Oct;49(5):457-460. doi: 10.1111/age.12695. Epub 2018 Jul 12.

PMID:
29999543
4.

A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses.

Bellone RR, Liu J, Petersen JL, Mack M, Singer-Berk M, Drögemüller C, Malvick J, Wallner B, Brem G, Penedo MC, Lassaline M.

Int J Cancer. 2017 Jul 15;141(2):342-353. doi: 10.1002/ijc.30744. Epub 2017 May 8.

Supplemental Content

Loading ...
Support Center